The cellular control switches are regulated through an extensive network of interactive intracellular signal transduction pathways, such as the mitogen-activated protein kinase (MAPK) family. The MAPK pathways may play an important role in the inappropriate inflammatory responses that lead to systemic inflammatory response syndrome or multiple organ dysfunction syndrome. Therefore, elucidating the activation status of the MAPK pathways may be a method to identify patients at risk for systemic inflammatory response syndrome/multiple organ dysfunction syndrome. Also, manipulating the proper pathways may improve patients' outcomes. However, the MAPK family is part of a complex interactive network, which may initiate an unpredictable reaction to the indiscriminate inhibition or activation of a single component. A major challenge is to elucidate the principles by which the network is assembled, so a more tissue-and temporal-specific approach can be used. (Crit Care Med 2002; 30[Suppl.]:S74 -S79) KEY WORDS: mitogen-activated protein kinase; extracellular signal-regulated kinase; c-Jun N-terminal kinase; systemic inflammatory response syndrome; multiple organ dysfunction syndrome; adult respiratory distress syndrome; signal transduction; cytokine; critical care; p38
A n uncontrolled systemic response to overwhelming infection, ischemia-reperfusion injury, or extensive tissue damage may induce systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) (1) . SIRS appears to be a multistage response, with initial periods of systemic immunosuppression and periods of systemic immunohyperactivation (2) . Whatever the cause for SIRS, the normal control mechanisms for inflammatory cells, the on-off switches, are malfunctioning. These cellular "control switches" are regulated through extensive networks of interconnected intracellular signal transduction pathways (3) . These signaling pathways regulate cellular response by activating effector proteins and by modifying protein expression and transcription. At the molecular level, signaling transduction is achieved, in part, by activating or deactivating regulatory proteins through phosphorylation by protein kinases. The highly conserved mitogenactivated protein kinase (MAPK) superfamily is one of the major mechanisms used by human cells to transduce extracellular signals into a cellular response (4, 5) . Three important members of the human MAPK superfamily are the extracellular signal-regulated kinase (ERK), p38, and c-Jun N-terminal kinase (JNK). All three MAPK families are activated by dual phosphorylation on both adjacent threonine and tyrosine residues that are separated by a single amino acid, a tripeptide motif (6) . The intervening amino acid for ERK is glutamate (Thr-Glu-Tyr), for the p38 MAPK family is glycine (Thr-Gly-Tyr), and for the JNK family is proline (Thr-Pro-Tyr) (3, 7, 8) . The activation of the MAPK is the last step in a cascade of intracellular phosphorylation (9) . The classic MAPK cascade consists of three sequential intracellular protein kinase activation steps and is initiated when the first member, MAPK kinase kinase (MAPKKK), is activated ( Fig. 1 ). MAPKKK is a Ser/Thr kinase that phosphorylates and activates MAPK kinase (MAPKK). Subsequently, MAPKK activates a MAPK by dual phosphorylation on adjacent threonine and tyrosine residues. MAPKs are proline-directed protein kinases, meaning that they phosphorylate serine or threonine residues that are neighbors to proline (3) . In this manner, MAPKs activate other protein kinases, nuclear proteins, or transcription factors. Activation of the MAPK cascade is rapid and enables cells to respond to environmental changes in a prompt and regulated fashion. In this review, we will focus on the three major MAPK families and their potential clinical importance in critical care medicine.
p38 MAPK
p38 is one of the most important members of the family in control of inflammatory response. p38 is recognized as the MAPK that is activated in response to physiologic stress, lipopolysaccharide (LPS), osmotic stress, and ultraviolet exposure (10 -13) . p38 has been well conserved throughout evolution and is the mammalian homolog of the yeast HOG1. There have been five isoforms of the p38 group identified, p38␣ (also known as SAPK2), p38␤, p38␤2, p38␥ (also known as SAPK3), and p38␦ (7, 14 -18) . Selective expression of each isoform is different in various tissues. p38␣ is expressed in high levels in leukocytes and bone marrow, p38␤ is expressed in heart and brain, and p38␥ is expressed predominately in skeletal muscles (18, 19) . In addition, there are significant differences in preferred upstream activators, substrate specificity, and inhibitors among the isoforms. Pyridinyl imidazoles, such as SB203580 and SB202190, inhibit p38 MAPK function by binding to the ATP-containing pocket (20). However, this inhibition is not the same for all p38 isoforms. Although pyridinyl imidazoles are potent inhibitors of p38␣/␤/␤2, they do not inhibit p38␦ (7, 18) . In addition, two recent studies demonstrate that pyridinyl imidazoles also inhibit the function of JNK and cyclooxy-genase, a rate-limiting enzyme in prostaglandin biosynthesis (21, 22).
Two major upstream activators of p38 in leukocytes are MKK3 and MKK6. Other MKKs such as MKK4, a wellknown activator of JNK, may also activate p38 in certain cell lines, but a physiologic role for these pathways is not clear (7, 23) . The preferred upstream kinase is different for each isoform and cell type (24). MKK6 is poorly expressed in leukocytes (25, 26). In contrast, MKK3 is abundant in leukocytes, and multiple studies have demonstrated an important role for MKK3 in proinflammatory responses and cytokine expression (27, 28). In neutrophils, LPS selectively activates p38␣ via MKK3 and not MKK4 or MKK6 (16) . MKK6 is a common activator of p38␣/␤/ ␤2/␥/␦, whereas MKK3 activates p38␣/ ␥/␦ only (7, 17, 28) . Based on the level of tissue expression and studies in potent host inflammatory systems, it appears that MKK3-p38␣ axis is of primary importance. More proximally, there are multiple diverse serine/threonine kinases that act as MAPKKK for the p38 pathway, including TAK1 and ASK-1 (29). This diverse array of proximal kinases focuses the cellular inflammatory response to a wide range of receptor-mediated environmental stimuli.
MAP kinase-activated protein kinase-2 (MAPKAP-K2) and MAPKAP-K3 are two protein kinases that are major physiologic substrates for p38 (30 -34). MAP-KAP-K2/3 are serine protein kinases known to activate heat shock protein-27 (HSP-27) and cyclic AMP responsive ele-ments binding protein (CREB) (34 -36). HSP-27 is an actin binding protein that helps to repair the actin cytoskeleton, inhibit apoptosis, and may have some anti-inflammatory properties (34, 37, 38). p38 also phosphorylates and activates transcription factor ATF-2. ATF-2 binds to cyclic AMP responsive elements (CREs), forms homodimer or heterodimer with c-Jun, and regulates expression of various inflammatory proteins (39, 40). Other known substrates for p38 are cytosolic phospholipase A 2 , myelin basic protein, MAP kinase-interacting kinase-1 (MNK1), myocyte-enhancer factor 2 (MEF2C), CHOP, SAP-1, and Elk-1 (30, 31, 41-48). Although similar stimuli induce nuclear factor-B and p38 activation, this process appears to be via separate pathways. Inhibition of p38 neither modulates nuclear factor-B DNA binding nor disrupts phosphorylation of its subunits (49 -51) . However, the two pathways may converge downstream, because p38 inhibition interferes with nuclear factor-B-dependent gene transcription (49 -52) .
Inflammatory stimuli, such as LPS, tumor necrosis factor (TNF), platelet activating factor, interleukin (IL)-1, and ischemia-reperfusion, induce p38 activation in innate immune cells, including monocytes, endothelial cells, and neutrophils (53) (54) (55) (56) (57) (58) . p38 activation is essential for expression of the proinflammatory phenotype in these cells. Monocyte/ macrophage expression of TNF, IL-1, IL-6, IL-8, and cycloxygenase-2 (COX-2) are p38 dependent (13, 59 -62) . In addition, p38 activation inhibits myelomonocyte apoptosis (63) . Neutrophil IL-8 production, oxidative burst, and elastase release are also p38 dependent (64, 65) . Similarly, TNF-and LPS-induced endothelial COX-2 expression, prostaglandin production, and E-selectin expression are p38 dependent (66, 67) .
JNK
JNK was originally identified as 54-kDa stress-activated protein kinase (SAPK) (68, 69) . JNK is activated in response to many of the stress-induced stimuli that activate p38, such as LPS, TNF, IL-1, osmotic stress, and ultraviolet radiation (6) . The JNK protein-kinases are encoded by three genes: JNK1, JNK2, and JNK3 (8) . The JNK1/2 are ubiquitously expressed, whereas JNK3 appears to be expressed only in brain, heart, and testis (6) .
The immediate upstream kinases for JNK activation are two MAPKKs: MKK4 (SEC1) and MKK7 (6, 23) . Similar to p38, the JNK pathway is activated by a large group of MAPKKKs (6) . More proximally, both JNK and p38 pathways can be activated through Cdc42/Rac/PAK axis (70 -72) . Cdc42 and Rac are members of rho family of guanosine triphosphate (GTP)binding proteins that play an important role in cytoskeletal rearrangement. PAK, p21-activated kinases, are a potential target for Cdc42 and Rac, which can then activate p38 and JNK cascades (70 -72) .
Activated JNK phosphorylates ATF-2, Elk-1 and c-Jun. JNK plays an important role in AP-1 activation, in part, because of c-Jun phosphorylation. In contrast to p38 and ERK, there are no known specific inhibitors of JNK. Most evidence supporting JNK involvement in proinflammatory signal transduction is based on biochemical/transfection assays and knockout studies. Therefore, the role of JNK in the inflammatory response is not as clear as p38 (8) . JNK appears to play an important role in TNF expression (73) (74) (75) (76) . JNK may also play an important role in T-cell proliferation, differentiation, and IL-2 production (77) . Similarly, TNF-induced Eselectin expression in the endothelial cells requires JNK activation (67) . Both JNK and p38 play an important and complex role in cell apoptosis (78 -81) .
ERK
ERK was the first identified and is the best characterized of all MAPK families. The MAPK cascade of Ras, Raf, MEK1/2, and ERK1/2 has been studied in detail (4, 5) . Although p38 and JNK are classically known as "stress-induced" MAPK, ERK is thought to be a proliferation, transformation, and differentiation MAPK (82, 83) . ERK has two isoforms ERK1 and ERK2 (p44 and p42, respectively). The ERK cascade is activated in response to many mitogens, such as epidermal growth factor, platelet-derived growth factor, thromboxane A 2 , angiotensin II, transforming growth factor, and insulin (4, 84) . In addition, ERK is activated in response to LPS, osmotic stress, and adherence in monocytes and endothelial cells (57, 66, 85) . Adherence activates ERK through integrin-mediated activation of focal adhesion kinases (86, 87) . This ERK activation in response to extracellular matrix is important in monocyte/macrophage reprogramming for subsequent cytokine production (60, 85) . The ERK cascade follows the typical three-level MAPK sequential kinase activation process (Fig. 1 ). Activated Raf (MAPKKK) phosphorylates and activates MEK1/2 (MAPKK), which subsequently activates ERK1/2 (MAPK) by dual phosphorylation (88, 89) . The Raf family is a highly conserved serine-threonine kinase that is activated through its interaction with Ras (90, 91) . Ras is a G-protein that is activated through its interaction with Grb2-Sos (son of sevenless) complex, where Sos catalyzes the dislocation of guanosine diphosphate with the subsequent formation of Ras-GTP complex (82) . Only the GTP-bound form of Ras can bind to Raf and activate it in a manner that is not yet completely understood. Raf is recruited to the membrane by Ras, where it undergoes phosphorylation and oligomerization (29, 92, 93) . Both Ras and Raf are well-known protooncogenes, which demonstrates the importance of this pathway in cellular differentiation and proliferation (82) .
The downstream substrates of ERK are numerous, including MNK-1, Elk-1, and SAP-1 (29, 43, 94, 95). The flavone compound PD98059 inhibits MEK and, therefore, ERK activation (83, 96) . Use of PD98059 to study the ERK cascade is limited because of the other nonspecific effects of this drug, such as inhibition of COX (22). However, studies using PD98059 and other MEK inhibitors have demonstrated a probable role for ERK in the production of proinflammatory cytokines, such as TNF (60, 85 ).
An Interactive Network, Not Separate Pathways
The intracellular protein kinase pathways are part of a large interactive network. MAPK cascades share many upstream and downstream kinases and transcription factors that interact and integrate these pathways (Fig. 2 ). There is a complex cross-talk and signal convergence among the MAPKs (97) . It is known that p38 and ERK have feedback loops affecting their activation status (98) . JNK and p38 may have converging pathways through MKK4 activation (23, 99). Many of the upstream kinases and downstream substrates are the same for each of the major cascades (6, 29) . A major challenge in the study of intracellular signaling has been the elucidation of the principles by which the network of signaling protein kinases is assembled (100) . It appears that eukaryotic cells use scaffold, anchoring, and adaptor proteins extensively to route intracellular signal transduction (101, 102) . A number of studies indicate that MAPKs are targeted to specific intracellular sites, and this cytoskeletal spatial organization confers an extra level of substrate specificity (103) (104) (105) .
In this network, there are multiple parallel overlapping pathways. An example of this interconnected system is in the MAPK regulation of the AP-1 transcription factor (106) . MAPK pathways influence AP-1 activity by both increasing c-Fos and c-Jun transcription and/or increasing c-Jun activity (95) . p38, JNK, and ERK can phosphorylate the ternary complex factor Elk-1, which acts to increase c-Fos transcription. Both ERK and p38 can activate SAP-1, another ternary complex factor important in c-Fos transcription (47) . p38 can modulate AP-1 activity by phosphorylation of CREB (via MAPKAP-K2/3) and ATF-2 (39, 40, 107). JNK phosphorylates and increases transcription activity of c-Jun (6) . In this complex system, isolating one pathway is not only inadequate but also impossible.
Potential Role in Critical Care
The importance of the MAPK pathways in the control of the proinflammatory response is evident. Because SIRS and MODS appear to be the result of excessive systemic amplification and inappropriate attenuation of the inflammatory response, manipulation of MAPK signaling pathways may be a clinically relevant approach to prevent/cure SIRS and MODS in the critically ill ICU patient (108) .
First, it appears that delineating the activation status of MAPKs in inflammatory cells may enable the clinician to create an inflammatory portfolio and permit early identification of the "primed" or at risk patients. In response to a second stimulus, cells that are primed with an initial inflammatory stimulus, such as platelet activating factor, may produce several-fold higher cytokine levels than unprimed cells (53, 65) . Although analyses of baseline cytokine production fail to identify these primed cells, an increase in intracellular p38 activation has been shown to be an accurate marker to isolate the primed monocytes/macrophages (53, 65) . Before the second stimulus, the primed cells may not be phenotypically different from unprimed cells. However, looking "inside" at the MAPK activation status can accurately identify the primed monocytes/macrophages (53, 109) . In one clinical study, the p38 activation level of the alveolar macrophages accurately identified patients at risk for acute respiratory distress syndrome/MODS when multiple standardized clinical analyses failed to do so (109) . Another ex vivo laboratory study has implicated defective ERK activation in LPS-tolerant human monocytes (110) .
The ability to recognize a high-risk population via the status of MAPK activation has important clinical relevance. As mentioned, numerous studies have demonstrated attenuation of the proinflammatory response when the p38 MAPK cascade is blocked (13, 59 -62, 64 -67) . Inhibition of p38 also attenuates ischemia-reperfusion injury in heart and brain (111) (112) (113) . Intraperitoneal injection of a p38 inhibitor decreases pulmonary injury in a pancreatitis-induced acute respiratory distress syndrome model (114) . Therefore, one can potentially identify patients at risk and simultaneously devise treatment plans that are best matched to their proinflammatory status.
However, MAPK cascades are not simple linear systems. There is a complex interacting system of intracellular signal transduction pathways. In this complex network, systemic or local inhibition of one pathway may have unpredictable results. The problem becomes more complex when the whole body with its multiple different tissue types is considered. Activation of the same MAPK pathway in two different cell types may lead to the expression of two different mediators with opposing roles (115) . For instance, endothelial p38 activation induces prostacyclin production, which inhibits platelet aggregation (66) . In contrast, platelet p38 activation promotes platelet aggregation (41, 116). Hence, administration of a systemic p38 inhibitor may have variable, even opposing, results in the coagulation cascade. In addition, there is evidence to suggest that the hyperactivated inflammatory systems may not respond to MAPK inhibitors, as well as cells that are functioning within "normal" physiologic parameters (61) . Therefore, systemic administration of a MAPK inhibitor to "turn-off" a hyperactive system may not be capable of achieving the desired result. In a murine endotoxemia and pneumonia model, systemic administration of a p38 inhibitor failed to reduce TNF-␣ levels in the plasma and increased TNF-␣ levels in the lung homogenate (115) . These findings highlight the uncertainty of systemic administration of p38 or other MAPK inhibitors as an anti-inflammatory strategy. Last, as is common to most biochemical inhibitors, the known specific inhibitors of MAPKs are not highly specific and have other activities. SB203580, a p38 inhibitor, also inhibits COX and JNK and activates Raf-1 in vivo (21, 22, 117, 118) .
In conclusion, the MAPK pathways play a very important role in inflammatory signal transduction. Analyzing the activation status of selected MAPK cascades has the potential to identify the patients at highest risk for SIRS and MODS. Potentially, these pathways may also be the focus of therapeutic manipulation to alter the inflammatory status of the critically ill. However, caution is warranted because a generalized simple approach using systemic administration of MAPK inhibitors may not produce the desired effect. A tissue-specific approach using carefully defined selected time points may be required to achieve beneficial clinical response. tion of the structure and function of a new mitogen-activated protein kinase (p38beta kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. Embo J 1997; 16:1921-1933 
